Biogenic Synthesis of MgNOPs: A Revolutionary Frontier in Biomedical Advancements

At present, nanotechnology is developing at exponential rate because of its widespread applications in biomedical field. Traditionally, nanoparticles are fabricated through variety of physical and chemical approaches but because of their limited efficiency in life sciences, biogenic synthesis of nanoparticles has gained much attention. Biogenically fabricated MgONPs possess unique features that enabled their use in therapeutics and environmental biotechnology. Biogenically MgONPs can be fabricated by employing plant extracts (Manihot esculenta, Rhizophora lamarckii, Ocimum sanctum, Rosemary, Aloe vera, Orange, Artemisia abrotanum, Neem, Bauhinia purpurea), bacteria (S. coelicolor, A. johnsonii RTN), fungi (Aspergillus flavus TFR-12, Aspergillus brasiliensis TFR 2, white-button mushroom’s) and algae (S. whigti). These biogenically synthesized MgONPs are being reported as anti-fungal, antioxidant, antibacterial, anti-pyretic, anti-inflammatory and anti-cancer agents. Moreover, their photocatalytic activity is being discovered against certain organic dyes. This review focuses on biogenic synthesis of MgONPs, their applications in therapeutics and as antimicrobial agents as well as future prospects associated with their application in biomedical field.